DMPK & Translational PK Consulting
Turning Preclinical Data into clear, Development focused Decisions
For pharma, biotech and CRO teams who need PK/TK analysis, translational insight, and reports they can act on.
Representative PK outputs
Plasma concentration–time profile
Linear scale · representative preclinical PK
Who we work with
Pharma · Biotech · CROs · R&D Teams · DMPK Teams · Academic & Research Organizations
Supporting organizations that need reliable PK/DMPK analysis, scientific interpretation and translational insight without the overhead of a full-time specialist.
Led by Sahithi Yerrabelli — 10+ years in pharmaceutical DMPK, preclinical PK, translational pharmacokinetics, and scientific reporting.
“We don’t just analyze numbers. We translate pharmacokinetic data into insights that support better development decisions.”
Why SUHA Pharma Consulting
DMPK expertise built on experience, validated tools, and development-focused delivery.
10+ years pharma experience
Preclinical through translational PK.
WinNonlin & R analysis
Rigorous, validated PK/TK workflows.
Development-focused interpretation
Insights for the next decision, not data dumps.
Flexible & confidential
Project-based or fractional; MOU before data exchange.
Services
Five capabilities from raw data to development-ready reporting.
Preclinical PK & TK
NCA, compartmental analysis, exposure and TK interpretation.
Translational PK
Allometric scaling, human exposure and FIH dose estimation.
Modeling & Simulation
Scenario testing, dose optimization and profile prediction.
Tissue & Excretion
Distribution ratios, recovery and mass-balance calculations.
Scientific Reporting
Protocols, reports, tables, figures and presentations.
Our Process
Six structured steps from study intake to a development-ready decision.
- Study
- Data
- Analysis
- Interpretation
- Translation
- Decision